Thus, the potential increase in CD39−/+CD73+CD4+ cells in HPV− HNSCC patients may represent a heightened Th17 or Th1.17 inflammatory state compared to HPV+ HNSCC patients, possibly in response to different tumour aetiology and antigen expression. The gene discussed is CD4; the disease is neoplasm.